• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RU58841作为前列腺PC3细胞抗雄激素及断尾猕猴秃头皮局部抗脱发剂的评估。

Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques.

作者信息

Pan H J, Wilding G, Uno H, Inui S, Goldsmith L, Messing E, Chang C

机构信息

Department of Pathology, University of Rochester Medical Center, NY 14642, USA.

出版信息

Endocrine. 1998 Aug;9(1):39-43. doi: 10.1385/ENDO:9:1:39.

DOI:10.1385/ENDO:9:1:39
PMID:9798729
Abstract

The effect of androgen receptor transcriptional activation by RU58841, a nonsteroidal anti-androgen, was studied in the human prostate cancer PC3 cell line by cotransfection with wild-type androgen receptor (wt AR) and an androgen-responsive reporter (MMTV-ARE-CAT) construct. Anti-and rogens, hydroxyflutamide, and Casodex, and the antiestrogen, genistein, were studied in parallel for comparison with RU58841. The wt AR was activated only by the androgen dihydrotestosterone (DHT). Neither the anti-androgens nor antiestrogen can enhance AR transcriptional activity at 10(-11)-10(-7)M in PC3 cells. Hydroxyflutamide, RU58841, and Casodex, but not genistein, displayed competitively suppressive effects on DHT activation of wt AR. The potency of RU58841 was comparable to that of hydroxyflutamide. From this result, topical application of RU58841, which is considered to be a potential therapy for skin diseases, may induce systemic side effects. However, RU58841, on topical application, revealed a potent increase in density, thickening, and length of hair in the macaque model of androgenetic alopecia, whereas no systemic effects were detected. Together our results suggest that RU58841 may have potent antagonism to the wt AR and could be considered as a topically applied active anti-androgen for the treatment of androgen-dependent skin disorders, such as acne, androgenetic alopecia, and hirsutism.

摘要

通过与野生型雄激素受体(wt AR)和雄激素反应性报告基因(MMTV-ARE-CAT)构建体共转染,在人前列腺癌PC3细胞系中研究了非甾体类抗雄激素RU58841对雄激素受体转录激活的作用。同时研究了抗雄激素药物氟他胺和比卡鲁胺以及抗雌激素染料木黄酮,以便与RU58841进行比较。wt AR仅被雄激素双氢睾酮(DHT)激活。在PC3细胞中,抗雄激素和抗雌激素在10^(-11)-10^(-7)M浓度下均不能增强AR转录活性。氟他胺、RU58841和比卡鲁胺对wt AR的DHT激活表现出竞争性抑制作用,而染料木黄酮则无此作用。RU58841的效力与氟他胺相当。由此结果可知,被认为是一种潜在皮肤病治疗药物的RU58841局部应用可能会引起全身副作用。然而,在雄激素性脱发的猕猴模型中,RU58841局部应用可使毛发密度显著增加、变厚并增长,且未检测到全身效应。我们的研究结果共同表明,RU58841可能对wt AR具有强效拮抗作用,可被视为一种局部应用的活性抗雄激素药物,用于治疗雄激素依赖性皮肤病,如痤疮、雄激素性脱发和多毛症。

相似文献

1
Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques.RU58841作为前列腺PC3细胞抗雄激素及断尾猕猴秃头皮局部抗脱发剂的评估。
Endocrine. 1998 Aug;9(1):39-43. doi: 10.1385/ENDO:9:1:39.
2
A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice.一项关于非甾体类抗雄激素药物RU58841对在睾酮处理的裸鼠上维持的秃发头皮移植片的头发生长影响的对照研究。
Br J Dermatol. 1997 Nov;137(5):699-702.
3
RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism.
J Steroid Biochem Mol Biol. 1994 Jan;48(1):55-60. doi: 10.1016/0960-0760(94)90250-x.
4
A mouse model of androgenetic alopecia.雄激素性脱发的小鼠模型。
Endocrinology. 2010 May;151(5):2373-80. doi: 10.1210/en.2009-1474. Epub 2010 Mar 16.
5
Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.区分雄激素受体激动剂和拮抗剂:醋酸甲羟孕酮和二氢睾酮的不同激活机制。
Mol Endocrinol. 1999 Mar;13(3):440-54. doi: 10.1210/mend.13.3.0255.
6
The antiandrogen bicalutamide activates the androgen receptor (AR) with a mutation in codon 741 through the mitogen activated protein kinase (MARK) pathway in human prostate cancer PC3 cells.雄激素拮抗剂比卡鲁胺通过丝裂原活化蛋白激酶(MARK)通路在人前列腺癌 PC3 细胞中激活 741 密码子突变的雄激素受体(AR)。
Oncol Rep. 2010 Nov;24(5):1395-9. doi: 10.3892/or_00000998.
7
Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia.二氢睾酮通过激活 C57BL6 小鼠中的雄激素受体抑制毛发生长,模拟雄激素性脱发。
Biomed Pharmacother. 2021 May;137:111247. doi: 10.1016/j.biopha.2021.111247. Epub 2021 Jan 29.
8
RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia.RU 58841-肉豆蔻酸酯——用于痤疮和雄激素性脱发局部治疗的前药开发
Pharmazie. 2005 Jan;60(1):8-12.
9
Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP.抗雄激素可抑制人前列腺癌细胞LNCaP中依赖人雄激素受体的基因转录激活。
Prostate. 1994 Apr;24(4):176-86. doi: 10.1002/pros.2990240403.
10
Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells.雄激素受体共激活因子ARA70在人前列腺癌DU145细胞中促进抗雄激素的激动剂活性。
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7379-84. doi: 10.1073/pnas.95.13.7379.

引用本文的文献

1
An appraisal of laboratory models of androgenetic alopecia: A systematic review.雄激素性脱发实验室模型的评估:一项系统综述。
Skin Health Dis. 2021 Mar 5;1(2):e15. doi: 10.1002/ski2.15. eCollection 2021 Jun.
2
Drug discovery for alopecia: gone today, hair tomorrow.斑秃的药物研发:今日尚无药,明日新发长。
Expert Opin Drug Discov. 2015 Mar;10(3):269-92. doi: 10.1517/17460441.2015.1009892. Epub 2015 Feb 9.
3
Therapeutic androgen receptor ligands.治疗性雄激素受体配体

本文引用的文献

1
Dietary Estrogens Act through Estrogen Receptor-Mediated Processes and Show No Antiestrogenicity in Cultured Breast Cancer Cells.膳食雌激素通过雌激素受体介导的过程发挥作用,并且在培养的乳腺癌细胞中未显示出抗雌激素活性。
Environ Health Perspect. 1994 Jun;102(6-7):572-8. doi: 10.1289/ehp.94102572.
2
A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice.一项关于非甾体类抗雄激素药物RU58841对在睾酮处理的裸鼠上维持的秃发头皮移植片的头发生长影响的对照研究。
Br J Dermatol. 1997 Nov;137(5):699-702.
3
Hydroxyflutamide may not always be a pure antiandrogen.
Nucl Recept Signal. 2003;1:e009. doi: 10.1621/nrs.01009. Epub 2003 Sep 27.
4
[Androgenetic alopecia].雄激素性脱发
Hautarzt. 2004 Jan;55(1):89-111; quiz 110-1. doi: 10.1007/s00105-003-0673-4.
5
Roles of testosterone in the growth of keratinocytes through bald frontal dermal papilla cells.睾酮通过秃发前额真皮乳头细胞对角质形成细胞生长的作用。
Endocrine. 1999 Dec;11(3):321-7. doi: 10.1385/ENDO:11:3:321.
羟基氟他胺未必总是一种纯粹的抗雄激素药物。
Lancet. 1997 Mar 22;349(9055):852-3. doi: 10.1016/S0140-6736(05)61756-4.
4
Inhibition of hair growth by testosterone in the presence of dermal papilla cells from the frontal bald scalp of the postpubertal stumptailed macaque.在青春期后断尾猕猴额部秃发头皮的真皮乳头细胞存在的情况下,睾酮对毛发生长的抑制作用。
Endocrinology. 1997 Jan;138(1):356-61. doi: 10.1210/endo.138.1.4890.
5
Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones.三方甾体激素受体药理学:与多个效应位点的相互作用作为这些激素细胞特异性和启动子特异性作用的基础。
Mol Endocrinol. 1996 Feb;10(2):119-31. doi: 10.1210/mend.10.2.8825552.
6
Nilutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.尼鲁米特。对其药效学、药代动力学特性及在前列腺癌治疗中的疗效的综述。
Drugs Aging. 1993 Jan-Feb;3(1):9-25. doi: 10.2165/00002512-199303010-00002.
7
Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.抗雄激素对野生型和突变型(LNCaP)雄激素受体的转化及转录激活的影响。
J Steroid Biochem Mol Biol. 1993 Dec;46(6):731-6. doi: 10.1016/0960-0760(93)90313-l.
8
RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism.
J Steroid Biochem Mol Biol. 1994 Jan;48(1):55-60. doi: 10.1016/0960-0760(94)90250-x.
9
Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor.非甾体类抗雄激素药物:雄激素受体高亲和力配体的合成及生物学特性
J Steroid Biochem Mol Biol. 1994 Jan;48(1):111-9. doi: 10.1016/0960-0760(94)90257-7.
10
Soy intake and cancer risk: a review of the in vitro and in vivo data.大豆摄入量与癌症风险:对体外和体内数据的综述。
Nutr Cancer. 1994;21(2):113-31. doi: 10.1080/01635589409514310.